Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 28 of 28 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/20/21
End: 12/10/21
Due: 12/10/22
Phase: N/A
Priority: Normal
Start: 03/19/21
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 09/12/18
End: 01/23/25
Due: 01/23/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants | NCT05154136 | Arcus Biosciences, Inc. | user2@example.com | None | 2021-10-20 | 2021-12-10 | 2022-12-10 | - | - | 2025-07-14 |
| A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies | NCT04772989 | Arcus Biosciences, Inc. | user2@example.com | None | 2021-03-19 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |
| A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies | NCT03628677 | Arcus Biosciences, Inc. | user2@example.com | None | 2018-09-12 | 2025-01-23 | 2026-01-23 | - | - | 2025-07-14 |